---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-070560"
form_type: "8-K"
ticker: "DRIO"
cik: "0001533998"
company_name: "DarioHealth Corp."
filed_at: "2022-06-13T23:59:59+00:00"
generated_at: "2026-06-25T02:20:29.267496+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# DarioHealth secures $50M non-dilutive credit facility with OrbiMed; $25M drawn at close

## Summary
- $50M senior secured term loan from OrbiMed; $25M funded at closing, $25M available before June 30, 2023 subject to revenue thresholds.
- Interest rate: adjusted SOFR + 9.50% (floor 0.50%); warrants issued for 226,586 shares at $6.62, 7-year term.
- CEO states cash runway potentially >$100M, enabling multi-year business plan without further capital raises.
- Facility is non-dilutive, supports B2B segment growth and platform development.
- Obligations secured by substantially all assets; $10M minimum unrestricted cash covenant; subsidiary guarantees.

## SEC filing metadata
- accession: 0001104659-22-070560
- form_type: 8-K
- ticker: DRIO
- cik: 0001533998
- company_name: DarioHealth Corp.
- filed_at: 2022-06-13T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533998/000110465922070560/0001104659-22-070560-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533998/000110465922070560/tm2218154d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-070560
- JSON: https://secwatch.observer/filing/0001104659-22-070560.json
- Plain text: https://secwatch.observer/filing/0001104659-22-070560.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.